Position in SIGA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,124
+$438 QoQ
Shares Held
1,133
+64.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#135
of 160 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $8,299,759 across 12 Drug Manufacturers - Specialty & Generic names. SIGA ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
39,698 | $4,404,096 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
65,730 | $1,617,615 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
24,799 | $897,723 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
25,398 | $797,497 | |
| 5 | ZTS |
Zoetis Inc.
|
5,315 | $381,935 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
213 | $115,409 | |
| 7 | ALKS |
Alkermes plc.
|
700 | $36,680 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,242 | $21,499 |
All Filings in SIGA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,124 | 1,133 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,686 | 689 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,751 | 614 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $5,718 | 625 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $889,699 | 136,457 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,216,625 | 222,012 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,012,552 | 168,478 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $1,098,265 | 162,706 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||